Evaluation of plasma carboxy-terminal cross-linking telopeptide of type I collagen concentration in horses
Authors:
- Nicholas R. HoyleNHNicholas R. Hoyle
- Annick GabrielAGAnnick Gabriel
- Olaf HarsOHOlaf Hars
- Charlotte SandersenCSCharlotte Sandersen
- Hélène AmoryHAHélène Amory
- Benoit RemyBRBenoit Remy
- 1 January 2004
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 65 (1) , 104-109
Abstract
Objective —To evaluate a human assay for quantification of carboxy-terminal cross-linking telopeptide of type I collagen (CTX-I), assess the influence of age on plasma CTX-I concentration, investigate the relationship between plasma CTX-I and serum osteocalcin concentrations, and determine whether concentrations of plasma CTX-I or serum osteocalcin fluctuate in circadian manner in horses. Horses —75 clinically normal horses. Procedure —Cross-reactivity between equine serum CTX-I and CTX-I antibodies in an automated electrochemiluminescent sandwich antibody assay (ECLIA) was evaluated via a specificity test (ie, dilution test) and recovery calculation. Serum osteocalcin concentration was measured with an equine-specific osteocalcin radioimmunoassay. To analyze diurnal variations in plasma CTX-I and serum osteocalcin concentrations, blood samples were obtained hourly during a 24-hour period. Results —Results of the dilution test indicated good correlation ( r > 0.99) between expected serum CTX-I concentrations and measured serum CTX-I concentrations. The calculated CTX-I recovery was 97.6% to 109.9%. Plasma CTX-I and serum osteocalcin concentrations were correlated. Plasma CTX-I concentration was inversely correlated with age of the horse. No significant circadian variations in plasma CTX-I and serum osteocalcin concentrations were detected. Conclusions and Clinical Relevance —Results suggest that the fully automated CTX-I ECLIA can be used for evaluation of plasma and serum samples from horses and may be a useful tool to monitor bone metabolism changes. Horses in this study did not have notable diurnal fluctuations in serum osteocalcin and plasma CTX-I concentrations. ( Am J Vet Res 2004;65:104–109)Keywords
This publication has 46 references indexed in Scilit:
- Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapyBone, 2000
- Comparison of bone mineral content and biochemical markers of bone metabolism in stall‐ vs. pasture‐reared horsesEquine Veterinary Journal, 1999
- Influence of Age and Sex in Serum Osteocalcin Levels in Thoroughbred HorsesArchives of Physiology and Biochemistry, 1999
- Characterization of Urinary Degradation Products Derived from Type I CollagenJournal of Biological Chemistry, 1997
- Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal womenJournal of Bone and Mineral Research, 1996
- Biochemical Markers of Bone MetabolismAnnals of Medicine, 1993
- Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal womenJournal of Bone and Mineral Research, 1992
- Osteocalcin: Diagnostic Methods and Clinical ApplicationsCritical Reviews in Clinical Laboratory Sciences, 1991
- Calcium-dependent .alpha.-helical structure in osteocalcinBiochemistry, 1982
- An improved radioemmunoassay of serum gastrin using commercial kitClinica Chimica Acta, 1975